Treatment groups
|
No of GV oocytes
|
GV-arrest
|
Metaphase l
|
Telophase l
|
Metaphase ll
|
---|
miR-130b precursor
|
189
|
8.2 ± 0.1
|
8.3 ± 3.3
|
10.1 ± 5.5a
|
73.5 ± 10.1a
|
miR-130b inhibitor
|
204
|
8.9 ± 3.1
|
6.7 ± 3.9
|
30.1 ± 7.8b
|
52.8 ± 4.4b
|
Scramble
|
192
|
7.4 ± 0.9
|
6.8 ± 4.1
|
15.3 ± 7.8a
|
69.7 ± 9.7a
|
Uninjected control
|
191
|
7.3 ± 0.8
|
6.7 ± 2.8
|
13.0 ± 5.9a
|
72.3 ± 6.1a
|
- Different letters of superscripts in the same column indicate significant difference (P ≤ 0.05) between treatment groups. GV Germinal vesicle, SD standard deviation